New evidence shows GnRH antagonist stimulation outperforms PPOS for oocyte yield in young high-risk IVF patients, supporting more individualized stimulation choices.
Since December 2022, the nationwide control policy on the Coronavirus disease 2019 (COVID-19) epidemic has been changed in China. Fertility and in vitro fertilization (IVF) centers are receiving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback